Drug Shortage Report for TEVA-MYCOPHENOLATE
| Report ID | 2278 |
| Drug Identification Number | 02364883 |
| Brand name | NOVO-MYCOPHENOLATE |
| Common or Proper name | MYCOPHENOLATE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MYCOPHENOLATE MOFETIL |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | L04AA |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2017-03-01 |
| Estimated end date | 2017-04-03 |
| Actual end date | 2017-04-15 |
| Shortage status | Resolved |
| Updated date | 2017-04-25 |
| Company comments | Allocation of Inventory. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-04-25 | French | Compare |
| v3 | 2017-04-25 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v1 | 2017-03-14 | English | Compare |
Showing 1 to 4 of 4